Population Studies: Exposome studies and health disparities (Milestone 1.P)
Timeline Start - End2024 - 2025
Research Implementation AreaPopulation Studies and Precision Medicine
Expand current efforts to address health disparities research questions relevant to AD/ADRD by leveraging new and existing exposome AD/ADRD studies, including the impact of institutional and policy-level drivers of health inequities in AD/ADRD risk (i.e., factors categorized as forms of structural racism).
- Develop and promote practical and effective ways to improve population-representativeness of AD/ADRD research resources, ensuring wide-spread inclusivity across all groups, including NIH-designated priority populations (including, but not limited to, race, ethnicity, nativity, gender, immigration status, sexual orientation, gender identity, socioeconomic status).
- Ensure that AD/ADRD research resources include the collection of data relevant to addressing health disparities research questions relevant to AD/ADRD.
Summary of Key Accomplishments
This milestone has yet to be initiated. Accomplishments are forthcoming.
The key accomplishments summary is current as of July 2022.
- NOT-AG-21-033: Health Disparities and Alzheimer's Disease
- NOT-AG-22-022: Administrative Supplements to Support Research Infrastructure on Exposome Studies in Alzheimer's Disease (AD) and AD-Related Dementias (ADRD)
Research Programs and Resources
- The Influence of Structural Racism on Incidence of Alzheimer's Disease and Related Dementias (ADRD) in Black women
- Supplements funded under NOT-AG-22-022 in FY22